XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue (Tables)
 9 Months Ended
Sep. 30, 2018
Revenue [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
The cumulative effect of the changes made to our condensed consolidated January 1, 2018 balance sheet for the adoption of ASC 606 was as follows:
($ in millions)
Balance at December 31, 2017
 
Adjustments Due to ASC 606
 
Balance at January 1, 2018
Assets:
 
 
 
 
 
Accounts receivable, net
$
253.2

 
$
25.0

 
$
278.2

Inventories
215.2

 
(20.8
)
 
194.4

Other current assets
39.2

 
(8.4
)
 
30.8

 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Other current liabilities
$
77.0

 
$
(13.7
)
 
$
63.3

Deferred income taxes
10.4

 
3.0

 
13.4

Other long-term liabilities
42.6

 
(4.9
)
 
37.7

Retained earnings
1,178.2

 
11.4

 
1,189.6

The impact of the adoption of ASC 606 on our condensed consolidated income statement for the three months ended September 30, 2018 was as follows:
($ in millions)
As Reported
 
Balances without Adoption of ASC 606
 
Effects of Change Higher/(Lower)
Net sales
$
431.7

 
$
423.5

 
$
8.2

Cost of goods and services sold
296.1

 
290.3

 
5.8

Research and development
10.1

 
10.0

 
0.1

Other (income) expense
(0.2
)
 
(0.4
)
 
0.2

Income tax expense
8.0

 
7.8

 
0.2

Net income
$
55.2

 
$
53.2

 
$
2.0

The impact of the adoption of ASC 606 on our condensed consolidated income statement for the nine months ended September 30, 2018 was as follows:
($ in millions)
As Reported
 
Balances without Adoption of ASC 606
 
Effects of Change Higher/(Lower)
Net sales
$
1,294.9

 
$
1,294.4

 
$
0.5

Cost of goods and services sold
882.7

 
878.9

 
3.8

Research and development
30.5

 
30.5

 
—

Other expense
4.0

 
3.5

 
0.5

Income tax expense
26.5

 
27.5

 
(1.0
)
Net income
$
154.9

 
$
157.6

 
$
(2.7
)
The impact of the adoption of ASC 606 on our condensed consolidated balance sheet as of September 30, 2018 was as follows:
($ in millions)
As Reported
 
Balances without Adoption of ASC 606
 
Effects of Change Higher/(Lower)
Assets:
 
 
 
 
 
Accounts receivable, net
$
302.9

 
$
277.6

 
$
25.3

Inventories
206.8

 
228.5

 
(21.7
)
Other current assets
43.1

 
54.2

 
(11.1
)
 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Other current liabilities
$
76.4

 
$
90.2

 
$
(13.8
)
Deferred income taxes
11.7

 
9.7

 
2.0

Other long-term liabilities
43.8

 
48.2

 
(4.4
)
Retained earnings
1,312.7

 
1,304.0

 
8.7
Disaggregation of Revenue [Table Text Block]
The following table presents the approximate percentage of our net sales by market group:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2018
 
2017 (1)
 
2018
 
2017 (1)
Biologics
21
%
 
23
%
 
21
%
 
23
%
Generics
21
%
 
22
%
 
21
%
 
21
%
Pharma
34
%
 
33
%
 
35
%
 
35
%
Contract-Manufactured Products
24
%
 
22
%
 
23
%
 
21
%
 
100
%
 
100
%
 
100
%
 
100
%
(1) As noted above, prior period amounts have not been adjusted under the modified retrospective method.
The following table presents the approximate percentage of our net sales by product category:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2018
 
2017 (1)
 
2018
 
2017 (1)
High-Value Components
41
%
 
42
%
 
42
%
 
42
%
Standard Packaging
31
%
 
32
%
 
32
%
 
33
%
Delivery Devices
4
%
 
4
%
 
3
%
 
4
%
Contract-Manufactured Products
24
%
 
22
%
 
23
%
 
21
%
 
100
%
 
100
%
 
100
%
 
100
%
(1) As noted above, prior period amounts have not been adjusted under the modified retrospective method.
The following table presents the approximate percentage of our net sales by geographic location:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2018
 
2017 (1)
 
2018
 
2017 (1)
Americas
51
%
 
50
%
 
48
%
 
51
%
Europe, Middle East, Africa
41
%
 
42
%
 
44
%
 
41
%
Asia Pacific
8
%
 
8
%
 
8
%
 
8
%
 
100
%
 
100
%
 
100
%
 
100
%
(1) As noted above, prior period amounts have not been adjusted under the modified retrospective method.
Change in Contract with Customer, Asset and Liability [Abstract]
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:
 
($ in millions)
Contract assets, December 31, 2017
$
7.5

Contract assets, September 30, 2018
7.6

Change in contract assets - increase (decrease)
$
0.1

 
 
Deferred income, December 31, 2017
$
(33.6
)
Deferred income, September 30, 2018
(30.0
)
Change in deferred income - decrease (increase)
$
3.6